Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Exenatide Adjunctive Treatment in Schizophrenia
NCT02417142Phase 4Completed
- Sponsor
- University of Massachusetts
- Start
- Sep 2014
- Primary completion
- Jul 2019
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of exenatide in schizophrenia, schizoaffective disorder, sponsored by University of Massachusetts. Started Sep 2014; status: completed.
02
Drugs
exenatide
03
Conditions
schizophreniaschizoaffective disorder
Beyond the preview
Go deeper on NCT02417142.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02417142.